Susan Moran - Jun 23, 2025 Form 4 Insider Report for GLYCOMIMETICS INC (CBIO)

Role
Director
Signature
/s/ Barbara Bispham, as attorney-in-fact for Susan Moran
Stock symbol
CBIO
Transactions as of
Jun 23, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 06:51 PM
Previous filing
Jun 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moran Susan Director C/O/ CRESCENT BIOPHARMA, INC., 300 FIFTH AVENUE, WALTHAM /s/ Barbara Bispham, as attorney-in-fact for Susan Moran 2025-06-23 0001835225

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBIO Stock Option (Right to Buy) Award $0 +9.02K $0.00 9.02K Jun 23, 2025 Ordinary Shares 9.02K $15.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase shares of the Issuer's ordinary shares and vests in full on the earlier of (i) June 23, 2026 or (ii) the date of the Issuer's next annual meeting of shareholders, in each case, subject to the Reporting Person's continued service to the Issuer.